molecular biology
+ Enlarge Image
Lee Rubin, director of translational medicine at HSCI and the other senior author on the research team, said that “our goals were to try to as discretely and specifically as possible guide the cells through the deprogramming process” from the adult state to the embryonic-like state. Photograph by Kris Snibbe/Harvard Staff Photographer |
Harvard team reports major step forward in cell reprogrammingA team of Harvard Stem Cell Institute (HSCI) researchers has made a major advance toward producing induced pluripotent stem cells, or iPS cells, that are safe enough to use in treating diseases in patients. |
molecular biology links: |
Other molecular biology storiesall recent title) ?> stories» |
